Shelter Pharma Ltd vs Supriya Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Shelter Pharma Ltd is ₹ 30.39 as of 30 Apr 15:30 . The P/E Ratio of Shelter Pharma Ltd changed from 9.2 on March 2024 to 5.8 on March 2025 . This represents a CAGR of -20.60% over 2 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 31.4 on March 2025 . This represents a CAGR of 4.73% over 4 years The Market Cap of Shelter Pharma Ltd changed from ₹ 56.84 crore on March 2024 to ₹ 41.85 crore on March 2025 . This represents a CAGR of -14.19% over 2 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 5903 crore on March 2025 . This represents a CAGR of 10.45% over 4 years The revenue of Shelter Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 209.05 crore as compare to the Sep '25 revenue of ₹ 202.56 crore. This represent the growth of 3.2% The ebitda of Shelter Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 74.24 crore as compare to the Sep '25 ebitda of ₹ 75.37 crore. This represent the decline of -1.5% The net profit of Shelter Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 49.68 crore over 7 quarters. This represents a CAGR of 6.30% The Dividend Payout of Shelter Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About Shelter Pharma Ltd

Shelter Pharma Limited originally named as 'Shelter Pharmacy', was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat.
Company primarily focus in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space. The Company was founded in 1965 by Mr. N. R. Gandhi, a well-known practitioner of Ayurveda and Unani healthcare systems.
Introduction of new generation has added zeal and ambition to the company resulting in reinvention of entire company.
Aggressive and bold strategic decisions taken by the management has put it on fast growth track. The Company started with a few products about decades back.
However, over a period of time, it has added products to portfolio through in-house R & D efforts backed by sound knowledge of Ayurveda.

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of Shelter Pharma Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Shelter Pharma Ltd or Supriya Lifescience Ltd?

Market cap of Shelter Pharma Ltd is 50 Cr while Market cap of Supriya Lifescience Ltd is 5,589 Cr

What are the key factors driving the stock performance of Shelter Pharma Ltd and Supriya Lifescience Ltd?

The stock performance of Shelter Pharma Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shelter Pharma Ltd and Supriya Lifescience Ltd?

As of May 4, 2026, the Shelter Pharma Ltd stock price is INR ₹30.39. On the other hand, Supriya Lifescience Ltd stock price is INR ₹694.5.

How do dividend payouts of Shelter Pharma Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Shelter Pharma Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.